Printer Friendly

AMERICAN DRUG SCREENS, INC. REPORTS RESULTS

 AMERICAN DRUG SCREENS, INC. REPORTS RESULTS
 BOCA RATON, Fla., Nov. 12 /PRNewswire/ -- American Drug Screens,


Inc. (NASDAQ: ADSI;ADSIW) today reported net income of $157,274 on revenues of $7,686,330 for the third quarter ended Sept. 30, 1992. This compares to net income of $161,467 on revenues of $2,892,859 for the same period in 1991.
 Pre-tax income for the third quarter ended Sept. 30, 1992 increased to $272,274 from $161,467 in the comparable period in 1991.
 For the nine months ended Sept. 30, 1992, net income was $417,895 on revenues of $18,025,940 compared to net income of $290,728 on revenues of $7,313,848 for the comparable period in 1991.
 The continued increase in revenues and profits is due to the company's expanded operations into the latex medical examination glove industry.
 ADS is a medical products and services company currently active in testing for drugs of abuse and the marketing and distribution of latex gloves and related products. ADS management plans on continuing its growth through acquiring and operating medical related businesses.
 The company is currently in the process of moving its corporate headquarters to Boca Raton, Fla.
 AMERICAN DRUG SCREENS, INC.
 UNAUDITED STATEMENT OF OPERATIONS (OOOs)
 Nine Nine Three Three
 Months Months Months Months
 Ended Ended Ended Ended
 9/30/92 9/30/91 9/30/92 9/30/91
 REVENUES $18,026 $7,313 $7,686 $2,893
 PRE-TAX INCOME 703 291 272 161
 PROVISION FOR TAXES 285 --- 115 ---
 NET INCOME $ 418 $ 291 $ 157 $ 161
 -0- 11/12/92
 /CONTACT: Larry Howell or John Simonelli, 405-949-1722, or David Natan, 407-278-0499, all of American Drug Screens, Inc./
 (ADSI ADSIW) CO: American Drug Screens, Inc. ST: Florida IN: MTC SU: ERN


JB-AW -- FL004 -- 0188 11/12/92 12:41 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 12, 1992
Words:301
Previous Article:FLETCHER CHALLENGE CANADA LTD. DECLARES DIVIDEND
Next Article:OCCIDENTAL PETROLEUM DECLARES COMMON DIVIDEND
Topics:


Related Articles
DRUG SCREENING SYSTEMS REPORTS SECOND QUARTER/SIX MONTHS RESULTS
DRUG SCREENING REPORTS THIRD QUARTER/NINE MONTHS RESULTS
DRUG SCREENING SYSTEMS REPORTS FOURTH QUARTER, 12 MONTHS RESULTS
DRUG SCREENING SYSTEMS REPORTS 2ND QUARTER/SIX MONTHS RESULTS
American Bio Medica Announces Distribution Agreement With CannAmm
American Bio Medica Completes $1.5 Million Financing
International Murex Signs Distribution Agreement With American Bio Medica For Rapid Drugs of Abuse Test
American Bio Medica Announces Distribution Agreement With a Subsidiary of International Murex Technologies
Nanogen Expands Point-of-Care Product Line to Include Drugs of Abuse Tests.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters